Catalyst Clinical Research Europe, Ltd.

POWER SEARCH PRICING

SOLUTIONS

catalyst clinical research europe, ltd. Company Information

Live

EstablishedSmallHigh

Company Number

08872035

Next Accounts

Sep 2025

Industry

Research and experimental development on biotechnology

Directors

Patricia McNamara

Nicholas Dyer

Shareholders

catalyst clinical research llc

Group Structure

View All

Contact

Registered Address

block 11, suite 2, 2nd floor, alderley park, macclesfield, SK10 4TG

Website

www.aptusclinical.com

catalyst clinical research europe, ltd. Estimated Valuation

£10.7m

Pomanda estimates the enterprise value of CATALYST CLINICAL RESEARCH EUROPE, LTD. at £10.7m based on an EBITDA of £1.9m and a 5.73x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Catalyst Clinical Research Europe, Ltd. is a live company located in macclesfield, SK10 4TG with a Companies House number of 08872035. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in January 2014, it's largest shareholder is catalyst clinical research llc with a 100% stake. Catalyst Clinical Research Europe, Ltd. is a established, small sized company, Pomanda has estimated its turnover at £4.8m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Catalyst Clinical Research Europe, Ltd. a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 3 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

2 Strong

6 Regular

3 Weak

Size

annual sales of £4.8m, make it in line with the average company (£4.4m)

Growth

3 year (CAGR) sales growth of 16%, show it is growing at a similar rate (13.9%)

EXPORT

Catalyst Clinical Research Europe, Ltd.'s latest turnover from December 2023 is estimated at £4.8 million and the company has net assets of -£913.2 thousand. According to their latest financial statements, Catalyst Clinical Research Europe, Ltd. has 52 employees and maintains cash reserves of £799.9 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2023	Dec 2022	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015
Turnover	4,784,720	4,302,392	3,362,202	2,757,191	3,074,203	2,034,304	2,078,287	1,696,049	1,913,060	1,219,738
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	2,176,286	1,999,412	1,629,863	1,309,169	1,456,864	998,288	937,812	826,608	1,038,369	669,089
Gross Profit	2,608,435	2,302,980	1,732,339	1,448,022	1,617,338	1,036,015	1,140,475	869,441	874,691	550,649
Admin Expenses	767,188	4,694,879	2,232,517	1,689,220	1,473,794	1,074,367	996,678	921,801	770,104	425,686
Operating Profit	1,841,247	-2,391,899	-500,178	-241,198	143,544	-38,352	143,797	-52,360	104,587	124,963
Interest Payable	0	17,186	12,211	15,056	8,634	5,105	159	153	0	0
Interest Receivable	30,296	26,797	5,808	955	583	2,822	1,816	647	705	429
Pre-Tax Profit	1,871,543	-2,382,288	-506,581	-255,298	135,493	-40,635	145,454	-51,866	105,293	125,391
Tax	-467,886	0	0	0	-25,744	0	-27,636	0	-21,058	-25,078
Profit After Tax	1,403,657	-2,382,288	-506,581	-255,298	109,749	-40,635	117,818	-51,866	84,234	100,313
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Retained Profit	1,403,657	-2,382,288	-506,581	-255,298	109,749	-40,635	117,818	-51,866	84,234	100,313
Employee Costs	4,409,589	3,515,481	2,571,432	2,236,000	1,771,614	1,136,655	811,207	406,443	1,130,935	771,057
Number Of Employees	52	45	34	32	26	17	13	7	20	14
EBITDA*	1,873,672	-2,389,430	-480,601	-225,405	157,424	-31,612	152,746	-49,384	105,618	124,963

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Dec 2022	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015
Tangible Assets	109,872	27,161	32,077	30,582	34,656	25,407	28,276	4,922	7,898	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	109,872	27,161	32,077	30,582	34,656	25,407	28,276	4,922	7,898	0
Stock & work in progress	0	0	0	0	0	0	0	0	0	0
Trade Debtors	596,911	313,794	433,148	481,332	627,966	395,789	476,000	477,570	339,281	179,869
Group Debtors	404,716	245,675	0	0	0	0	0	0	0	0
Misc Debtors	854,590	424,529	551,959	257,157	206,986	348,561	220,191	287,404	164,133	0
Cash	799,872	354,248	371,781	1,177,011	733,296	432,504	319,924	406,609	110,669	171,410
misc current assets	0	0	0	0	0	0	0	0	0	0
total current assets	2,656,089	1,338,246	1,356,888	1,915,500	1,568,248	1,176,854	1,016,115	1,171,583	614,083	351,279
total assets	2,765,961	1,365,407	1,388,965	1,946,082	1,602,904	1,202,261	1,044,391	1,176,505	621,981	351,279
Bank overdraft	0	0	0	0	0	0	0	4,886	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0
Trade Creditors	777,399	0	552,347	284,564	360,853	328,366	452,079	407,190	239,383	249,966
Group/Directors Accounts	11,231	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	34,945	28,504	21,999	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0
other current liabilities	2,863,112	3,677,152	1,277,817	1,228,522	783,027	506,029	335,067	629,168	197,051	0
total current liabilities	3,651,742	3,677,152	1,830,164	1,548,031	1,172,384	856,394	787,146	1,041,244	436,434	249,966
loans	0	0	0	326,858	103,318	129,257	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0
provisions	27,468	5,161	0	5,811	6,585	5,742	5,742	1,580	0	0
total long term liabilities	27,468	5,161	0	332,669	109,903	134,999	5,742	1,580	0	0
total liabilities	3,679,210	3,682,313	1,830,164	1,880,700	1,282,287	991,393	792,888	1,042,824	436,434	249,966
net assets	-913,249	-2,316,906	-441,199	65,382	320,617	210,868	251,503	133,681	185,547	101,313
total shareholders funds	-913,249	-2,316,906	-441,199	65,382	320,617	210,868	251,503	133,681	185,547	101,313

	Dec 2023	Dec 2022	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015
Operating Activities
Operating Profit	1,841,247	-2,391,899	-500,178	-241,198	143,544	-38,352	143,797	-52,360	104,587	124,963
Depreciation	32,425	2,469	19,577	15,793	13,880	6,740	8,949	2,976	1,031	0
Amortisation	0	0	0	0	0	0	0	0	0	0
Tax	-467,886	0	0	0	-25,744	0	-27,636	0	-21,058	-25,078
Stock	0	0	0	0	0	0	0	0	0	0
Debtors	872,219	245,509	246,618	-96,463	90,602	48,159	-68,783	261,560	323,545	179,869
Creditors	777,399	-284,564	267,783	-76,289	32,487	-123,713	44,889	167,807	-10,583	249,966
Accruals and Deferred Income	-814,040	2,448,630	49,295	445,495	276,998	170,962	-294,101	432,117	197,051	0
Deferred Taxes & Provisions	22,307	-650	-5,811	-774	843	0	4,162	1,580	0	0
Cash flow from operations	519,233	-471,523	-415,952	239,490	351,406	-32,522	-51,157	290,560	-52,517	169,982
Investing Activities
capital expenditure	-115,136	952	-21,072	-11,719	-23,129	-3,871	-32,303	0	-8,929	0
Change in Investments	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-115,136	952	-21,072	-11,719	-23,129	-3,871	-32,303	0	-8,929	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	11,231	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	-34,945	-34,945	6,441	6,505	21,999	0	0	0	0
Long term loans	0	-326,858	-326,858	223,540	-25,939	129,257	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	63	0	0	4	0	0	1,000
interest	30,296	9,611	-6,403	-14,101	-8,051	-2,283	1,657	494	705	429
cash flow from financing	41,527	-352,192	-368,206	215,943	-27,485	148,973	1,661	494	705	1,429
cash and cash equivalents
cash	445,624	-822,763	-805,230	443,715	300,792	112,580	-86,685	295,940	-60,741	171,410
overdraft	0	0	0	0	0	0	-4,886	4,886	0	0
change in cash	445,624	-822,763	-805,230	443,715	300,792	112,580	-81,799	291,054	-60,741	171,410

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for catalyst clinical research europe, ltd.. Get real-time insights into catalyst clinical research europe, ltd.'s credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for catalyst clinical research europe, ltd. by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in SK10 area or any other competitors across 12 key performance metrics.

CATALYST CLINICAL RESEARCH EUROPE, LTD. group structure

Catalyst Clinical Research Europe, Ltd. has no subsidiary companies.

Ultimate parent company

CATALYST CLINICAL RESEARCH LLC

#0105192

1 parent

CATALYST CLINICAL RESEARCH EUROPE, LTD.

08872035

CATALYST CLINICAL RESEARCH EUROPE, LTD. Shareholders

catalyst clinical research llc

100%

Catalyst Clinical Research Europe, Ltd. currently has 2 directors. The longest serving directors include Ms Patricia McNamara (Apr 2022) and Mr Nicholas Dyer (Apr 2022).

officer	country	age	start	end	role
Ms Patricia McNamara	United Kingdom	56 years	Apr 2022	-	Director
Mr Nicholas Dyer	United Kingdom	54 years	Apr 2022	-	Director

P&L

December 2023

turnover

4.8m

+11%

operating profit

1.8m

gross margin

54.6%

+1.85%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

-913.2k

-0.61%

total assets

2.8m

+1.03%

cash

799.9k

+1.26%

net assets

Total assets minus all liabilities

Similar Companies

nonacus limited

3.5

epistem limited

azotic technologies (europe) limited

uk peptides ltd

3.5

oxford mestar limited

company number

08872035

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

January 2014

ultimate parent company

CATALYST CLINICAL RESEARCH LLC

previous names

aptus clinical limited (April 2023)

address

block 11, suite 2, 2nd floor, alderley park, macclesfield, SK10 4TG

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to catalyst clinical research europe, ltd.. Currently there are 2 open charges and 2 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for CATALYST CLINICAL RESEARCH EUROPE, LTD.. This can take several minutes, an email will notify you when this has completed.

catalyst clinical research europe, ltd. Company Information

catalyst clinical research europe, ltd. Estimated Valuation

catalyst clinical research europe, ltd. Estimated Valuation

catalyst clinical research europe, ltd. Estimated Valuation

Catalyst Clinical Research Europe, Ltd. Overview

Catalyst Clinical Research Europe, Ltd. Health Check

CATALYST CLINICAL RESEARCH EUROPE, LTD. financials

catalyst clinical research europe, ltd. Credit Report and Business Information

Catalyst Clinical Research Europe, Ltd. Competitor Analysis

catalyst clinical research europe, ltd. Ownership

catalyst clinical research europe, ltd. directors

catalyst clinical research europe, ltd. company details

catalyst clinical research europe, ltd. Charges & Mortgages

catalyst clinical research europe, ltd. Capital Raised & Share Issues BETA

catalyst clinical research europe, ltd. Companies House Filings - See Documents